Khloris Biosciences

Khloris Biosciences is a biotechnology company developing the treatment of cardiovascular, oncology, and other diseases. The company aims to harness the immunotherapeutic potential of human-induced pluripotent stem cells (iPSCs) for drug discovery, vaccine, and cell therapies.